Brief: Cereno Scientific: Patent Grant in US
31/10/2018 15:39
Oct 31 (Reuters) - Cereno Scientific AB CRNOSb.TE :
* CERENO SCIENTIFIC'S PATENT IS GRANTED IN US FOR USE OF DRUG CANDIDATE CS1
* US PATENT WILL BE VALID THROUGH 2035
* PATENT CAN BE EXTENDED FOR ADDITIONAL FIVE YEAR MAXIMUM
Source text for Eikon: ID:nWkrJ4dJ2
Further company coverage: CRNOSb.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Carries Out Directed Share Issue Of SEK 60 Mln
Brief: Cereno Scientific Strengthens Patent Protection For Cs1 In Canada
Sweden's Cereno Scientific Q1 net loss widens amid clinical development
Brief: Cereno Scientific Q1 Loss After Financial Items SEK 28.6 Mln
Brief: Cereno Enters Collaboration With PHA Europe & Global